The House Energy and Commerce Oversight and Investigations Subcommittee hearing on reforming the 340B outpatient drug discount program showcased the ongoing lack of broad bipartisan agreement on legislation addressing the issue.
Bipartisan House Support Remains Elusive In 340B Reform Effort
Republicans continue to take the lead on advancing reforms, while Democrats warn proposals could endanger a government program supporting safety-net care.
